Patient-reported Outcomes and Late Toxicity After Postprostatectomy Intensity-modulated Radiation Therapy (European Urology)

Patient-reported long-term quality of life (QOL) and physician-assigned late toxicity remain favorable following postprostatectomy intensity-modulated radiation therapy. Certain clinical and dosimetric risk factors may help guide decision making in consideration of preserving QOL and limiting late toxicity.